Nicotinamide in Hemodialysis Patients With Hyperphosphatemia
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 252 participants.
Also called NCT01200784
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 252 participants
- Sponsor
- Medice Arzneimittel Pütter GmbH & Co KG
- Registry
-
NCT01200784 -
2009-015821-34
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany
- Registry status
- Completed
Technical summary
Registry record NCT01200784. Randomized; double masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2011-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Nicotinamide in Hemodialysis Patients With Hyperphosphatemia
- Acronym
- DONATO
- Condition
- Chronic Kidney Disease
- Condition
- Hemodialysis
- Condition
- Hyperphosphatemia
- Intervention (Drug)
- Nicotinamide
- Lead sponsor
- Medice Arzneimittel Pütter GmbH & Co KG
Record details
- Record id
cardio:ct-nct01200784- Content hash
cee4cc3985f70738f0675a797e2ee4fe9fcdc6b1a0aa3f5e14a8e0425ada1daa